南華早報: US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval. 中國售價 280 美元，美國售價 8,892 美元：中國抗癌新藥獲得 FDA 批准.

That why US hate China. They can do it cheaper so American drug company can’t rip off their patient. Cancer drugs are life saver. You don’t jack up the price for profit. 這就是美國討厭中國的原因。 他們可以做得更便宜，這樣美國製藥公司就不能欺騙他們的病人。 抗癌藥物是救星。 你不會為了利潤而提高價格

https://www.scmp.com/news/china/science/article/3243209/cocaine-price-hike-chinas-new-cancer-drug-approved-us-will-cost-30-times-more

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US. 繼特瑞普利單抗獲得美國食品藥物管理局批准後，又有兩種中國製造的抗癌藥物獲准在美國銷售.